Welldoc builds AI-powered, clinically validated digital health technology for personalised chronic and cardiometabolic care. Founded in 2005 and headquartered in Columbia, Maryland, with operations in Bangalore, India, the company develops machine-learning systems intended for regulated clinical use - a setting in which model development sits alongside rigorous clinical validation and regulatory compliance. Its technical domains span artificial intelligence, healthcare AI, data analytics and chronic care management platforms.
The company's Welldoc Chronic Care Platform delivers multi-condition support across pre-diabetes, diabetes, hypertension, heart failure, weight management and other cardiometabolic conditions, generating personalised insights for users. Per user each year, the platform analyses more than 680 unique metrics across 80 health domains, drawing on half a billion data points. The system operates within a substantial regulatory and intellectual-property footprint: 11 FDA 510(k) clearances and 67 patents.
Welldoc supports 53 million covered lives and serves the healthcare, payer, pharmaceutical and chronic disease management sectors in the United States. Teams work across the U.S. and India, and the company describes itself as an award-winning business focused on innovation and healthcare-ready AI. Further details are available at welldoc.com.
